Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

PPAR-gamma effects on the vasculature

¹Division of Endocrinology, Diabetes, and Hypertension, University of California-Los Angeles, 900 Veteran Ave, Suite 24-130, Box 957073, Los Angeles, CA 90095, USA.

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research

|February 24, 2001

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Systematic evaluation of validated type 2 diabetes and glycaemic trait loci for association with insulin clearance.

Diabetologia·2013

Same author

Insulin clearance: confirmation as a highly heritable trait, and genome-wide linkage analysis.

Diabetologia·2012

Same author

Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes.

Heart (British Cardiac Society)·2006

Same author

PPARgamma and atherosclerosis: effects on cell growth and movement.

Arteriosclerosis, thrombosis, and vascular biology·2001

Same author

Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration.

Journal of cardiovascular pharmacology·2001

Same author

TNFalpha induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2.

Atherosclerosis·2001